Tumors undergoing rejection induced by monoclonal antibodies of the IgG2a isotype contain increased numbers of macrophages activated for a distinctive form of antibody-dependent cytolysis.
- 1 June 1984
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 81 (11) , 3506-3510
- https://doi.org/10.1073/pnas.81.11.3506
Abstract
Monoclonal antibodies of the IgG2a isotype specifically inhibit the growth of human tumors in nude mice; tumors in mice given no antibody, an antibody of the IgG2a isotype that does bind to the tumor cells, or an antibody of the IgG2b isotype grow progressively. In the present work it is demonstrated that tumors of mice given the IgG2a antibody are essentially masses of necrosis, while tumors from the control mice are sheets of healthy tumor cells. Tumors of the treated mice, in comparison to controls, contain an increased number of macrophages, and these macrophages are activated for a distinct form of cytolysis dependent on antibodies of the IgG2a isotype. The data suggest that changes in the number and function of intratumoral macrophages are a major component of tumor destruction mediated by IgG2a antibodies.Keywords
This publication has 14 references indexed in Scilit:
- The Cell Biology of Macrophage ActivationAnnual Review of Immunology, 1984
- Sequential activation of murine mononuclear phagocytes for tumor cytolysis: differential expression of markers by macrophages in the several stages of development.The Journal of Immunology, 1983
- Therapy of murine leukemia with monoclonal antibody against a normal differentiation antigen.The Journal of Experimental Medicine, 1983
- IgG2a monoclonal antibodies inhibit human tumor growth through interaction with effector cells.Proceedings of the National Academy of Sciences, 1982
- Immunologic control of the ascites form of murine adenocarcinoma 755. V. Antibody-directed macrophages mediate tumor cell destruction.The Journal of Immunology, 1981
- Immunologic control of the ascites form of murine adenocarcinoma 755. IV. Characterization of the protective antibody in hyperimmune serum.The Journal of Immunology, 1981
- Mac‐1: a macrophage differentiation antigen identified by monoclonal antibodyEuropean Journal of Immunology, 1979
- Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies.Proceedings of the National Academy of Sciences, 1979
- Suppression of Antibody-Sensitized Tumor Cells by Macrophages: Insufficient Supply or Activation of Macrophages within Large TumorsThe Journal of Immunology, 1979
- Immunologic Factors Influencing the Intra-tumor Localization of ADCC Effector CellsThe Journal of Immunology, 1978